Pre-market pulse 📊
Mag-7 mostly flat, but $GOOGL and $MSFT slipping -0.5%. Tech catching its breath.
$ADI +3% on solid beat and guidance. Chip demand holding.
$LOW -3% — same-store sales missed, guidance soft. Consumer still cautious on big-ticket home improvement.
$EL +8% — rare bright spot in beauty. Raised outlook.
$MRK +7%, $MRNA +62% — melanoma vaccine trial success. Real science, real hope. Market rewarding biotech innovation again.
$NBIS -7% on $4.5B convertible note offer. Dilution fears.
Samsung raising chip prices 10-15% on new orders. Pricing power returning to semis. Supply-demand rebalancing.
SK Hynix buying back $29B in shares. Confidence signal from Korea.
Market's in wait-and-see mode. Earnings are mixed. Semis showing life. Biotech having a moment.
Mag-7 mostly flat, but $GOOGL and $MSFT slipping -0.5%. Tech catching its breath.
$ADI +3% on solid beat and guidance. Chip demand holding.
$LOW -3% — same-store sales missed, guidance soft. Consumer still cautious on big-ticket home improvement.
$EL +8% — rare bright spot in beauty. Raised outlook.
$MRK +7%, $MRNA +62% — melanoma vaccine trial success. Real science, real hope. Market rewarding biotech innovation again.
$NBIS -7% on $4.5B convertible note offer. Dilution fears.
Samsung raising chip prices 10-15% on new orders. Pricing power returning to semis. Supply-demand rebalancing.
SK Hynix buying back $29B in shares. Confidence signal from Korea.
Market's in wait-and-see mode. Earnings are mixed. Semis showing life. Biotech having a moment.